View Future GrowthFlask 과거 순이익 실적과거 기준 점검 0/6Flask은 연평균 11.9%의 비율로 수입이 증가해 온 반면, Semiconductor 산업은 연평균 0.2%의 비율로 증가했습니다. 매출은 연평균 4.1%의 비율로 증가했습니다.핵심 정보11.90%순이익 성장률40.82%주당순이익(EPS) 성장률Semiconductor 산업 성장률23.50%매출 성장률4.15%자기자본이익률-149.48%순이익률-177.29%최근 순이익 업데이트31 Mar 2024최근 과거 실적 업데이트Reported Earnings • Apr 02Full year 2023 earnings released: ₩287 loss per share (vs ₩178 loss in FY 2022)Full year 2023 results: ₩287 loss per share (further deteriorated from ₩178 loss in FY 2022). Revenue: ₩22.8b (down 39% from FY 2022). Net loss: ₩37.5b (loss widened 75% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 26Full year 2022 earnings released: ₩188 loss per share (vs ₩237 loss in FY 2021)Full year 2022 results: ₩188 loss per share. Revenue: ₩39.7b (up 65% from FY 2021). Net loss: ₩22.6b (loss widened 15% from FY 2021).Reported Earnings • Nov 19Third quarter 2020 earnings released: ₩34.00 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩10.0b (up 36% from 3Q 2019). Net loss: ₩2.63b (loss narrowed 65% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 47% per year.모든 업데이트 보기Recent updates공시 • Mar 17Flask Co., Ltd., Annual General Meeting, Mar 31, 2026Flask Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 167, songpa-daero, songpa-gu, seoul South Korea공시 • Mar 18Flask Co., Ltd., Annual General Meeting, Mar 31, 2025Flask Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 11, beobwon-ro 11-gil, songpa-gu, seoul South Korea공시 • Nov 30Flask Co., Ltd. announced that it expects to receive KRW 11.999999625 billion in funding from B&M HoldingsFlask Co., Ltd. announced a private placement of 15,209,125 common shares at a price of KRW 789 for gross proceeds of KRW 11,999,999,625 on November 29, 2024. The transaction includes participation from returning investor, B&M Holdings. The transaction has been approved by the board of directors of the company. The payment date of the transaction is December 20, 2024. The issuance is subject to full protection for 1 year.Reported Earnings • Apr 02Full year 2023 earnings released: ₩287 loss per share (vs ₩178 loss in FY 2022)Full year 2023 results: ₩287 loss per share (further deteriorated from ₩178 loss in FY 2022). Revenue: ₩22.8b (down 39% from FY 2022). Net loss: ₩37.5b (loss widened 75% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.공시 • Mar 14Flask Co., Ltd. announced that it expects to receive KRW 14.9999994 billion in fundingFlask Co., Ltd. announced a private placement to issue 16,666,666 shares at an issue price of KRW 900 for the gross proceeds of KRW 14,999,999,400 on March 13, 2024. The transaction will include participation from new investor Human Wellness for 16,666,666 shares. The transaction has been approved by the shareholders of the company and is expected to close on March 18, 2024. The securities are restricted to a hold period of 1 year.분석 기사 • Mar 06Some Confidence Is Lacking In Flask Co., Ltd.'s (KOSDAQ:041590) P/SWhen close to half the companies in the Semiconductor industry in Korea have price-to-sales ratios (or "P/S") below...New Risk • Nov 14New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩130.4b (US$98.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (₩130.4b market cap, or US$98.7m).New Risk • Oct 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (8.6% increase in shares outstanding).New Risk • Oct 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩128.9b (US$95.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Shareholders have been diluted in the past year (8.6% increase in shares outstanding). Market cap is less than US$100m (₩128.9b market cap, or US$95.8m).Reported Earnings • Mar 26Full year 2022 earnings released: ₩188 loss per share (vs ₩237 loss in FY 2021)Full year 2022 results: ₩188 loss per share. Revenue: ₩39.7b (up 65% from FY 2021). Net loss: ₩22.6b (loss widened 15% from FY 2021).Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩2,120, the stock trades at a trailing P/E ratio of 29.9x. Average trailing P/E is 17x in the Semiconductor industry in South Korea. Total returns to shareholders of 3.9% over the past three years.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₩2,680, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 17x in the Semiconductor industry in South Korea. Total returns to shareholders of 26% over the past three years.Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩1,310, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 16x in the Semiconductor industry in South Korea. Total loss to shareholders of 47% over the past three years.공시 • Aug 20GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) acquired additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) for KRW 18.02 billion.GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) acquired additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) for KRW 18.02 billion on August 19, 2021. GemVax&KAEL acquired 10.8 million shares through its own funds and now holds 23.64% stake after completion of the transaction. GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) completed the acquisition of additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) on August 19, 2021.분석 기사 • Apr 10Investors Will Want Gemvaxzio's (KOSDAQ:041590) Growth In ROCE To PersistIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...분석 기사 • Mar 06What Type Of Returns Would Gemvaxzio's(KOSDAQ:041590) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...분석 기사 • Jan 12Gemvaxzio (KOSDAQ:041590) Is Carrying A Fair Bit Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Jan 05New 90-day high: ₩847The company is up 14% from its price of ₩744 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 38% over the same period.Reported Earnings • Nov 19Third quarter 2020 earnings released: ₩34.00 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩10.0b (up 36% from 3Q 2019). Net loss: ₩2.63b (loss narrowed 65% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 47% per year.공시 • Jul 30Enerzent Co., Ltd. (KOSDAQ:A041590) cancelled the acquisition of an unknown stake in Zio International Inc.Enerzent Co., Ltd. (KOSDAQ:A041590) agreed to acquire an unknown stake in Zio International Inc. for KRW 14.9 billion on June 3, 2019. Under the terms of the transaction, Enerzent will issue 2.8 million new shares for the consideration. Enerzent Co., Ltd. (KOSDAQ:A041590) cancelled the acquisition of an unknown stake in Zio International Inc. on June 3, 2020.공시 • Jul 01+ 1 more updateGemvaxzio Co., Ltd. announced that it has received KRW 12.8 billion in fundingOn June 29, 2020, Gemvaxzio Co., Ltd. (KOSDAQ:A041590) closed the transaction.공시 • Jun 20Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,LtdOn June 18, 2020, Gemvaxzio Co., Ltd. (KOSDAQ:A041590) closed the transaction.매출 및 비용 세부 내역Flask가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A041590 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Mar 2420,748-36,78317,55211,05631 Dec 2322,760-37,52917,33011,45730 Sep 2322,442-30,87415,1417,21230 Jun 2327,141-31,67415,7705,73231 Mar 2330,752-30,86315,0084,34431 Dec 2237,367-21,41013,3392,70430 Sep 2238,463-15,74110,1371,52730 Jun 2234,758-16,7107,70982531 Mar 2234,075-13,1705,72920031 Dec 2124,071-19,6665,425030 Sep 2136,475-8,1135,642030 Jun 2141,805-2,5145,360031 Mar 2141,008-1,1135,761031 Dec 2045,768-3305,337030 Sep 2034,694-43,7037,873030 Jun 2032,055-49,8517,8501531 Mar 2024,741-68,6377,3691531 Dec 1918,236-71,3346,9191530 Sep 1911,987-46,4603,5341530 Jun 1913,827-40,8982,958031 Mar 1921,349-20,8352,210-16431 Dec 1825,448-9,1933,467930 Sep 1829,919-4,4933,8235030 Jun 1827,873-4,8234,03231531 Mar 1825,100-6,8444,59577931 Dec 1735,808-11,9843,09776330 Sep 1718,017-7,231-4,14695730 Jun 1734,537-10,108-1,17379031 Mar 1744,468-14,3171,75459531 Dec 1647,634-18,2185,39065230 Sep 1671,705-15,96613,01268230 Jun 1652,157-14,66910,64366831 Mar 1638,953-11,6657,61473531 Dec 1544,806-8,0965,04952230 Sep 1362,6044,5235,962030 Jun 1371,1816,9195,5870양질의 수익: A041590 은(는) 현재 수익성이 없습니다.이익 마진 증가: A041590는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A041590는 수익성이 없지만 지난 5년 동안 연평균 11.9%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 A041590의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: A041590은 수익성이 없어 지난 해 수익 성장률을 Semiconductor 업계(5.6%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A041590는 현재 수익성이 없으므로 자본 수익률이 음수(-149.48%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSemiconductors 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/06/25 04:14종가2024/03/28 00:00수익2024/03/31연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Flask Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Apr 02Full year 2023 earnings released: ₩287 loss per share (vs ₩178 loss in FY 2022)Full year 2023 results: ₩287 loss per share (further deteriorated from ₩178 loss in FY 2022). Revenue: ₩22.8b (down 39% from FY 2022). Net loss: ₩37.5b (loss widened 75% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 26Full year 2022 earnings released: ₩188 loss per share (vs ₩237 loss in FY 2021)Full year 2022 results: ₩188 loss per share. Revenue: ₩39.7b (up 65% from FY 2021). Net loss: ₩22.6b (loss widened 15% from FY 2021).
Reported Earnings • Nov 19Third quarter 2020 earnings released: ₩34.00 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩10.0b (up 36% from 3Q 2019). Net loss: ₩2.63b (loss narrowed 65% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 47% per year.
공시 • Mar 17Flask Co., Ltd., Annual General Meeting, Mar 31, 2026Flask Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 167, songpa-daero, songpa-gu, seoul South Korea
공시 • Mar 18Flask Co., Ltd., Annual General Meeting, Mar 31, 2025Flask Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 11, beobwon-ro 11-gil, songpa-gu, seoul South Korea
공시 • Nov 30Flask Co., Ltd. announced that it expects to receive KRW 11.999999625 billion in funding from B&M HoldingsFlask Co., Ltd. announced a private placement of 15,209,125 common shares at a price of KRW 789 for gross proceeds of KRW 11,999,999,625 on November 29, 2024. The transaction includes participation from returning investor, B&M Holdings. The transaction has been approved by the board of directors of the company. The payment date of the transaction is December 20, 2024. The issuance is subject to full protection for 1 year.
Reported Earnings • Apr 02Full year 2023 earnings released: ₩287 loss per share (vs ₩178 loss in FY 2022)Full year 2023 results: ₩287 loss per share (further deteriorated from ₩178 loss in FY 2022). Revenue: ₩22.8b (down 39% from FY 2022). Net loss: ₩37.5b (loss widened 75% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
공시 • Mar 14Flask Co., Ltd. announced that it expects to receive KRW 14.9999994 billion in fundingFlask Co., Ltd. announced a private placement to issue 16,666,666 shares at an issue price of KRW 900 for the gross proceeds of KRW 14,999,999,400 on March 13, 2024. The transaction will include participation from new investor Human Wellness for 16,666,666 shares. The transaction has been approved by the shareholders of the company and is expected to close on March 18, 2024. The securities are restricted to a hold period of 1 year.
분석 기사 • Mar 06Some Confidence Is Lacking In Flask Co., Ltd.'s (KOSDAQ:041590) P/SWhen close to half the companies in the Semiconductor industry in Korea have price-to-sales ratios (or "P/S") below...
New Risk • Nov 14New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩130.4b (US$98.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (₩130.4b market cap, or US$98.7m).
New Risk • Oct 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (8.6% increase in shares outstanding).
New Risk • Oct 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩128.9b (US$95.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Shareholders have been diluted in the past year (8.6% increase in shares outstanding). Market cap is less than US$100m (₩128.9b market cap, or US$95.8m).
Reported Earnings • Mar 26Full year 2022 earnings released: ₩188 loss per share (vs ₩237 loss in FY 2021)Full year 2022 results: ₩188 loss per share. Revenue: ₩39.7b (up 65% from FY 2021). Net loss: ₩22.6b (loss widened 15% from FY 2021).
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩2,120, the stock trades at a trailing P/E ratio of 29.9x. Average trailing P/E is 17x in the Semiconductor industry in South Korea. Total returns to shareholders of 3.9% over the past three years.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₩2,680, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 17x in the Semiconductor industry in South Korea. Total returns to shareholders of 26% over the past three years.
Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩1,310, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 16x in the Semiconductor industry in South Korea. Total loss to shareholders of 47% over the past three years.
공시 • Aug 20GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) acquired additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) for KRW 18.02 billion.GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) acquired additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) for KRW 18.02 billion on August 19, 2021. GemVax&KAEL acquired 10.8 million shares through its own funds and now holds 23.64% stake after completion of the transaction. GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) completed the acquisition of additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) on August 19, 2021.
분석 기사 • Apr 10Investors Will Want Gemvaxzio's (KOSDAQ:041590) Growth In ROCE To PersistIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
분석 기사 • Mar 06What Type Of Returns Would Gemvaxzio's(KOSDAQ:041590) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...
분석 기사 • Jan 12Gemvaxzio (KOSDAQ:041590) Is Carrying A Fair Bit Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Jan 05New 90-day high: ₩847The company is up 14% from its price of ₩744 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 38% over the same period.
Reported Earnings • Nov 19Third quarter 2020 earnings released: ₩34.00 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩10.0b (up 36% from 3Q 2019). Net loss: ₩2.63b (loss narrowed 65% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 47% per year.
공시 • Jul 30Enerzent Co., Ltd. (KOSDAQ:A041590) cancelled the acquisition of an unknown stake in Zio International Inc.Enerzent Co., Ltd. (KOSDAQ:A041590) agreed to acquire an unknown stake in Zio International Inc. for KRW 14.9 billion on June 3, 2019. Under the terms of the transaction, Enerzent will issue 2.8 million new shares for the consideration. Enerzent Co., Ltd. (KOSDAQ:A041590) cancelled the acquisition of an unknown stake in Zio International Inc. on June 3, 2020.
공시 • Jul 01+ 1 more updateGemvaxzio Co., Ltd. announced that it has received KRW 12.8 billion in fundingOn June 29, 2020, Gemvaxzio Co., Ltd. (KOSDAQ:A041590) closed the transaction.
공시 • Jun 20Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,LtdOn June 18, 2020, Gemvaxzio Co., Ltd. (KOSDAQ:A041590) closed the transaction.